Q. SHetA2 Therapy, recently seen in the news, refers to:

[A] An immunotherapy used to stimulate the body's immune response against cervical cancer

[B] A small-molecule therapy designed to prevent HPV infection from progressing to cervical cancer

[C] A CAR-T cell therapy developed for the treatment of HPV-associated cancers

[D] A stem cell-based therapy for the regeneration of cervical tissue damaged by HPV infection

Answer: B
Notes:

Explanation: SHetA2 is an investigational small-molecule therapy that disrupts the interaction between HPV oncoproteins and host proteins, thereby preventing persistent HPV infection from progressing to cervical cancer. It is not an immunotherapy, CAR-T cell therapy, or stem cell-based therapy.

Source- IE

Blog
Academy
Community